申请人:Pfizer Inc.
公开号:US04547501A1
公开(公告)日:1985-10-15
A series of novel [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives wherein the amine group is optionally substituted with lower alkyl, phenylalkyl having up to three carbon atoms in the alkyl moiety or alkanoyl having from two to five carbon atoms, or the amine group alternatively completes a piperazino ring, the quinoxaline ring is optionally substituted with fluorine, chlorine, bromine or methoxy, and the triazolo ring is optionally substituted with lower alkyl, lower perfluoroalkyl or phenyl are disclosed. These novel compounds are useful for treatment of symptoms associated with depression. Also disclosed are pharmaceutical compositions containing the novel compounds of this invention and a method of using the compounds in the treatment of depression and fatigue.
一系列新型[1,2,4]三唑并[4,3-a]喹喔啉-4-胺衍生物,其中胺基可选择地被低烷基、苯基烷基(烷基部分含有最多三个碳原子)或有2至5个碳原子的烷酰基取代,或者胺基可选择地形成哌嗪环,喹喔啉环可选择地被氟、氯、溴或甲氧基取代,三唑环可选择地被低烷基、低全氟烷基或苯基取代。这些新型化合物可用于治疗与抑郁症状相关的症状。还公开了包含本发明的新型化合物的药物组合物以及使用这些化合物治疗抑郁症和疲劳的方法。